Showing 101-110 of 354 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Type I Interferons and B Cell Metabolism as Drivers of Type 1 Diabetes | Trustees of Indiana University | Jamie Felton | Cures | 01-February-2026 to 31-January-2029 | $682.534,00 |
| Role of ZBED3 in beta cell stress response and vulnerability against autoimmunity | Trustees of Indiana University | Erica Cai | Cures | 01-June-2026 to 29-February-2028 | $383.433,16 |
| Optimizing Approaches to Type 1 Diabetes Prediction and Intervention in the Adult Autoantibody Positive Population | Trustees of Indiana University | Emily Sims | Cures | 01-February-2026 to 31-January-2029 | $691.694,00 |
| Targeting type 1 Diabetes through Polyamines with DFMO | Trustees of Indiana University | Emily Sims | Cures | 01-October-2022 to 30-September-2027 | $3.693.701,00 |
| Defining the role of islet-derived extracellular vesicle PD-L1 cargo in type-1 diabetes | Trustees of Indiana University | Chaitra Rao | Cures | 01-March-2024 to 30-April-2027 | $215.972,69 |
| β Cell Mitochondrial Health as a Driver and Indicator of Immune Activation in Type 1 Diabetes | Trustees of Indiana University | Carmella Evans-Molina | Cures | 01-March-2026 to 28-February-2029 | $748.179,00 |
| Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes | Trustees of Indiana University | Amelia Linnemann | Cures | 01-October-2023 to 31-December-2026 | $560.000,00 |
| Determining the role of SSTR2 on PRL-2903-mediated glucagon secretion | Trustees of Columbia University in the City of New York | Xiaojuan Chen | Improving Lives | 01-April-2026 to 31-March-2027 | $199.999,39 |
| Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts | Trustees of Columbia University in the City of New York | Megan Sykes | Cures | 01-June-2024 to 31-May-2027 | $791.063,66 |
| Preclinical optimization of Treg therapy to reverse autoimmunity in T1D patient-derived immune systems | Trustees of Columbia University in the City of New York | Megan Sykes | Cures | 01-August-2026 to 31-July-2029 | $1.189.893,00 |